Fig. 3From: High sustained virologic response rates of sofosbuvir-based regimens in Chinese patients with HCV genotype 3a infection in a real-world settingPercentage of treatment naïve patients without and with cirrhosis who have achieved SVR12 with the different treatments analyzedBack to article page